{
    "nctId": "NCT02167932",
    "briefTitle": "The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer",
    "officialTitle": "Impact of a Physical Activity Program on Biomarkers of Aging During Adjuvant or Neoadjuvant Chemotherapy for Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Aging",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 127,
    "primaryOutcomeMeasure": "Compare the change in p16 from baseline to the end of chemotherapy for patients receiving a physical activity intervention to the historical value seen in a previous study",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* 21 to 59 years of age, female (A similar trial LCCC 1226 explores physical activity in women 60 years and older and is now in progress.\n* Histologically confirmed Stage I, II or III breast cancer (if the patient has had more than one breast cancer, then the most recent diagnosis)\n* Scheduled to begin an appropriate adjuvant or neo-adjuvant chemotherapy regimen as defined by NCCN guidelines (www.nccn.org). Patients receiving anti-HER-2 therapy are eligible but the intervention will only be tested during the chemotherapy portion of the regimen.\n* English speaking\n* IRB approved, signed written informed consent\n* Approval from their treating physician to engage in moderate-intensity physical activity\n* Patient-assessed ability to walk and engage in moderate physical activity\n* Willing and able to meet all study requirements.\n\nExclusion Criteria:\n\n* One or more significant medical conditions that in the physician's judgment preclude participation in the walking or strength training intervention.\n* Unable to walk or engage in moderate-intensity physical activity.",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT"
}